Test Cure Live logo

TEST CURE LIVE is a national hepatitis C awareness campaign that aims to engage and motivate people living with hepatitis C to speak to their doctor about getting testing and/or being cured of hepatitis C.

The TEST CURE LIVE campaign commenced with two pilot campaigns. The lessons learnt from the pilot projects informed the recent rollout of the campaign in Adelaide and Canberra in partnership with Hepatitis SA and Hepatitis ACT.

The campaign will next be rolled out in locations across Queensland, Tasmania, Western Australia and the Northern Territory.

Visit the Test Cure Live website.

Why do we need to raise awareness of hepatitis C cures?

Around 182,000 Australians live with chronic hepatitis C infection; a blood-borne virus which can lead to liver cancer and liver failure if not treated.

New highly-effective cures known as direct acting antivirals (DAAs) were first listed on the Pharmaceutical Benefits Scheme in March 2016. In comparison, previous therapies were gruelling and relatively ineffective.

Despite initial publicity many people living with hepatitis C remain unaware of the benefits or availability of the new cures. These Australians are missing out on potentially life-saving therapies which are readily available on prescription from their GP and can cure hepatitis C in as little as eight weeks.
Initial uptake was strong among people with chronic hepatitis C who were already engaged in care and/or anticipating the availability of the new cures. This group needed little encouragement to commence treatment. However, Australia appears to be following the same pattern as other countries, where once this initial wave of demand is satisfied, engaging others in care becomes much more challenging.

Who is TEST CURE LIVE targeting?

Many other organisations are targeting people who currently inject drugs. The TEST CURE LIVE campaign is, therefore, filling a gap and targeting people who do not currently inject drugs and who don’t have the benefit of learning about the cure through drug and alcohol harm reduction or treatment services.

The primary audience for the campaign is people 50 years+, living with hepatitis C with a higher proportion of males than females. The secondary audience for the campaign is people living with hepatitis C from Vietnamese, Chinese, Indian and Egyptian backgrounds.

Page updated: 1 July 2019